WO2002066513A3 - Humane zirkulierende lekti fragmente hf7072, hf7638 und hf14448 sowie ihre verwendung - Google Patents

Humane zirkulierende lekti fragmente hf7072, hf7638 und hf14448 sowie ihre verwendung Download PDF

Info

Publication number
WO2002066513A3
WO2002066513A3 PCT/EP2002/001720 EP0201720W WO02066513A3 WO 2002066513 A3 WO2002066513 A3 WO 2002066513A3 EP 0201720 W EP0201720 W EP 0201720W WO 02066513 A3 WO02066513 A3 WO 02066513A3
Authority
WO
WIPO (PCT)
Prior art keywords
fragments
lekti
human circulating
circulating
human
Prior art date
Application number
PCT/EP2002/001720
Other languages
English (en)
French (fr)
Other versions
WO2002066513A2 (de
Inventor
Michael Walden
Hans-Juergen Maegert
Peter Kreutzmann
Harald John
Ludger Staendker
Wolf-Georg Forssmann
Original Assignee
Ipf Pharmaceuticals Gmbh
Michael Walden
Hans-Juergen Maegert
Peter Kreutzmann
Harald John
Ludger Staendker
Wolf-Georg Forssmann
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipf Pharmaceuticals Gmbh, Michael Walden, Hans-Juergen Maegert, Peter Kreutzmann, Harald John, Ludger Staendker, Wolf-Georg Forssmann filed Critical Ipf Pharmaceuticals Gmbh
Publication of WO2002066513A2 publication Critical patent/WO2002066513A2/de
Publication of WO2002066513A3 publication Critical patent/WO2002066513A3/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8135—Kazal type inhibitors, e.g. pancreatic secretory inhibitor, ovomucoid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

Peptide HF7072, HF7638 oder HF14448 sowie deren biologisch aktive Fragmente, Analoga und/oder Derivate.
PCT/EP2002/001720 2001-02-19 2002-02-19 Humane zirkulierende lekti fragmente hf7072, hf7638 und hf14448 sowie ihre verwendung WO2002066513A2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10107997 2001-02-19
DE10107997.4 2001-02-19

Publications (2)

Publication Number Publication Date
WO2002066513A2 WO2002066513A2 (de) 2002-08-29
WO2002066513A3 true WO2002066513A3 (de) 2003-04-03

Family

ID=7674767

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2002/001720 WO2002066513A2 (de) 2001-02-19 2002-02-19 Humane zirkulierende lekti fragmente hf7072, hf7638 und hf14448 sowie ihre verwendung

Country Status (1)

Country Link
WO (1) WO2002066513A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003070953A1 (de) * 2002-02-22 2003-08-28 Ipf Pharmaceuticals Gmbh Verbindung zur inhibierung der serin-proteinasen und zur inhibierung von infektionen oder virusvermehrung: rld 8564
DE102009010942A1 (de) 2009-02-27 2010-09-02 Universitätsklinikum Schleswig-Holstein Serinprotease-Inhibitoren zur spezifischen Inhibition von Gewebs-Kallikreinen
KR20200021991A (ko) 2017-06-16 2020-03-02 아지트라 인코포레이티드 Lekti 발현 재조합 미생물을 사용하는 네테르톤 증후군의 치료를 위한 조성물 및 방법
CN115836085A (zh) 2020-03-31 2023-03-21 法里斯生物技术有限责任公司 用于预防和治疗病毒感染的多肽

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999033974A1 (de) * 1997-12-23 1999-07-08 Forssmann Wolf Georg Serin-proteinase-inhibitoren
WO2000078963A1 (de) * 1999-06-22 2000-12-28 Forssmann, Wolf-Georg Serin-proteinase-inhibitoren
WO2001064747A1 (en) * 2000-03-02 2001-09-07 Isis Innovation Limited Mutations in spink5 responsible for netherton's syndrome and atopic diseases

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999033974A1 (de) * 1997-12-23 1999-07-08 Forssmann Wolf Georg Serin-proteinase-inhibitoren
WO2000078963A1 (de) * 1999-06-22 2000-12-28 Forssmann, Wolf-Georg Serin-proteinase-inhibitoren
WO2001064747A1 (en) * 2000-03-02 2001-09-07 Isis Innovation Limited Mutations in spink5 responsible for netherton's syndrome and atopic diseases

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
MÄGERT H J ET AL: "LEKTI, a novel 15-domain type of human serine proteinase inhibitor.", THE JOURNAL OF BIOLOGICAL CHEMISTRY. UNITED STATES 30 JUL 1999, vol. 274, no. 31, AJ228139, 30 July 1999 (1999-07-30), pages 21499 - 21502, XP002220533, ISSN: 0021-9258, Retrieved from the Internet <URL:EBI> *
MÄGERT HANS JÜRGEN ET AL: "LEKTI: a multidomain serine proteinase inhibitor with pathophysiological relevance.", THE INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY. ENGLAND JUN 2002, vol. 34, no. 6, June 2002 (2002-06-01), pages 573 - 576, XP002220534, ISSN: 1357-2725 *

Also Published As

Publication number Publication date
WO2002066513A2 (de) 2002-08-29

Similar Documents

Publication Publication Date Title
ZA200407868B (en) 17alpha-Alkyl-17beta-oxy-estratrienes, uses thereof and pharmaceutical preparations.
HK1061679A1 (en) Phenylsulfonyl-1,3-dihydro-2h-indole-2-ibe derivatives, their preparation and their therapeutic use.
WO2003011115A3 (en) Peptide-based multimeric targeted contrast agents
WO2003074551A8 (en) Conjugates of therapeutic or cytotoxic agents and biologically active peptides
AU2002329873A1 (en) Halogenated calixpyrroles, calixpyridinopyrroles and calixpyridines, and uses thereof
AU2001264042A1 (en) 1,4-diazabicyclo(3.2.2)nonane-phenylisoxazole derivatives, preparation and therapeutic use thereof
AU6246199A (en) Human interleukin-b50, therapeutic uses
MXPA03010684A (es) Peptidos y el uso de los mismos para oscurecer la piel.
AU2001264044A1 (en) 1,4-diazabicyclo(3.2.2)nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation and therapeutic use thereof
AU7748200A (en) Hypoxia-related human genes, proteins, and uses thereof
AU2002327026A1 (en) Human and mouse beta-defensins, antimicrobial peptides
IL162134A0 (en) Human cDNAs and proteins, and uses thereof
WO2002066513A3 (de) Humane zirkulierende lekti fragmente hf7072, hf7638 und hf14448 sowie ihre verwendung
MXPA03008393A (es) Derivados de guanidina biciclicos y usos terapeuticos de los mismos.
GB0217548D0 (en) Four human zinc-finger-containing proteins:MDZ3.MDZ4,MDZ7 and MDZ12
AU2002230129A1 (en) Novel physiologically active peptide and use thereof
AU2002252773A1 (en) Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379
MXPA03006162A (es) Derivados de mikanolida, su preparacion y sus usos terapeuticos.
EP1571148A4 (de) 3-phenylcinnolinhomologon und dieses enthaltendes antitumormittel
AU2002343197A1 (en) Biologically active complex
AU2002241570A1 (en) Human proteins, polynucleotides encoding them and methods of using the same
AU2002340728A1 (en) Tt virus sequences in human tumoral tissue, agent for the detection thereof and tumoral therapy
IL161859A0 (en) 3-Heteroaryl-3.5-dihydro-4-oxo-4H-pyridazinoÄ4.5-BÜindole-1-carboxamide derivatives, their preparation and therapeutic use
AU2002354963A1 (en) Tropomyosin isoforms, and diagnostic and therapeutic uses therefor
AU2003275127A1 (en) P. ariasi polypeptides, p. perniciosus polypeptides and methods of use

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP